, Cancer du col de l'utérus / Données par localisation / Cancers / Maladies chroniques et traumatismes / Dossiers thématiques / Accueil

D. Sur,

D. Forman, C. De-martel, C. J. Lacey, I. Soerjomataram, J. Lortet-tieulent et al., Global Burden of Human Papillomavirus and Related Diseases. Vaccine, vol.30, pp.12-23, 2012.

S. De-sanjose, W. G. Quint, L. Alemany, D. T. Geraets, J. E. Klaustermeier et al., Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study, Lancet Oncol, vol.11, issue.11, pp.1048-56, 2010.

S. Collins, S. Mazloomzadeh, and H. Winter, High incidence of cervical human papillomavirus infection in women during their first sexual relationship, BJOG, vol.109, issue.1, pp.96-104, 2002.

D. Sur,

, Haute Autorité de Santé -GARDASIL, vol.9

D. Sur,

, World Health Organization. Meeting of the Global Advisory Committee on Vaccine Safety, vol.92, pp.393-402, 2017.

N. M. Scheller, H. Svanström, B. Pasternak, A. Langer-gould, L. Qian et al., Quadrivalent HPV vaccination and risk of multiple sclerosis and other demyelinating diseases of the central nervous system, JAMA Neurol, vol.313, pp.54-61, 2014.

, A Review of Clinical Trials of Human Papillomavirus Prophylactic Vaccines | Request PDF

D. Sur,

S. N. Tabrizi, J. M. Brotherton, J. M. Kaldor, S. R. Skinner, E. Cummins et al., Fall in human papillomavirus prevalence following a national vaccination program, J Infect Dis, vol.206, issue.11, pp.1645-51, 2012.

S. M. Garland, S. K. Kjaer, N. Muñoz, S. L. Block, D. R. Brown et al., Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience, Clin Infect Dis. 15 août, vol.63, issue.4, pp.519-546, 2016.

A. Söderlund-strand, I. Uhnoo, and J. Dillner, Change in Population Prevalences of Human Papillomavirus after Initiation of Vaccination: The High-Throughput HPV Monitoring Study, Cancer Epidemiol Biomarkers Prev. 1 déc, vol.23, issue.12, pp.2757-64, 2014.

D. Mesher, K. Soldan, R. Howell-jones, K. Panwar, P. Manyenga et al., Reduction in HPV 16/18 prevalence in sexually active young women following the introduction of HPV immunisation in England, Vaccine, vol.32, issue.1, p.3898718, 2013.

C. K. Fairley, J. S. Hocking, L. C. Gurrin, M. Y. Chen, B. Donovan et al., Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women, Sex Transm Infect, vol.85, issue.7, pp.499-502, 2009.

L. Baandrup, M. Blomberg, C. Dehlendorff, C. Sand, K. K. Andersen et al., Significant decrease in the incidence of genital warts in young Danish women after implementation of a national human papillomavirus vaccination program, Sex Transm Dis, vol.40, issue.2, p.13035, 2013.

H. Ali, B. Donovan, H. Wand, T. R. Read, D. G. Regan et al., Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data, BMJ, vol.346, p.2032, 2013.

D. M. Gertig, J. M. Brotherton, A. C. Budd, K. Drennan, G. Chappell et al., Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study, BMC Med, vol.11, p.227, 2013.

E. Crowe, N. Pandeya, J. M. Brotherton, A. J. Dobson, S. Kisely et al., Effectiveness of quadrivalent human papillomavirus vaccine for the prevention of cervical abnormalities: case-control study nested within a population based screening programme in Australia, BMJ, vol.348, p.3942076, 2014.

, Early Impact of Human Papillomavirus Vaccination on Cervical Neoplasia-Nationwide Follow-up of Young Danish Women | JNCI: Journal of the National Cancer Institute | Oxford Academic

D. Sur,

, Haut Conseil de la Santé Publique, HCSP. Recommandations vaccinales contre les infections à papillomavirus humains chez les hommes, 2016.

D. Sur,

L. Maladie,

R. Cohen, F. Denis, J. Gaudelus, T. Lery, H. Lepetit et al., HPV vaccination in France: uptake, costs and issues for the National Health Insurance

L. Groupe-d'étude and . Vaccinoscopie®, Couverture vaccinale : les ados en danger? Le point à l'occasion de la semaine de la vaccination, Med Mal Infect, vol.42, pp.139-179, 2012.

L. Fonteneau, J. P. Guthmann, and D. Lévy-bruhl, Estimation des couvertures vaccinales en France à partir de l'Échantillon généraliste des bénéficiaires (EGB) : exemples de la rougeole, de l'hépatite B et de la vaccination HPV. BEH 8-9 2013. Numéro thématique -De nouveaux outils pour améliorer la mesure de la couverture vaccinale en France

. Couverture-vaccinale-:-le-bilan-reste-contrasté-en...--mesvaccins,

A. Health and . Of, Australian Government Department of Health

D. M. Gertig, J. M. Brotherton, and M. Saville, Measuring human papillomavirus (HPV) vaccination coverage and the role of the National HPV Vaccination Program Register, Australia. Sex Health, Review. PubMed, vol.8, issue.2, pp.171-179, 2011.

, Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis, pp.30099-30106

D. Sur, , pp.30099-30106

. Australia, Human Papillomavirus and Related Cancers

D. Sur,

, National HPV Vaccination Program Register. HPV vaccination coverage by dose number (Australia) for males/females by age group in mid 2016. National HPV Vaccination Program Register, 2017.

, Ministère de la santé publique du canada Mise à jour des recommandations visant le calendrier d'immunisation

, Provincial / territorial screening and vaccine programs [Internet]. cancerview.ca

D. Sur,

, About HPV Vaccination -Statens Serum Institut

D. Sur,

, Årsrapporter om børnevaccinationsprogrammet

D. Sur,

P. Health-england, Human papillomavirus coverage in adolescent females in England 2015-16

, HPV vaccination programme: change from 3 to 2 doses -GOV.UK [Internet]. [cité 18 mars, 2017.

, Vaccination for Human Papillomavirus (HPV) (Indicator 22) [Internet]. Norwegian Institute of Public Health

D. Sur,

M. Drolet, É. Bénard, and M. C. Boily, Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and metaanalysis, Lancet Infect, vol.15, pp.565-80, 2015.

J. Cuzick, A. Castañón, and P. Sasieni, Predicted impact of vaccination against human papillomavirus 16/18 on cancer incidence and cervical abnormalities in women aged 20-29 in the UK, Br J Cancer. 2 mars, vol.102, issue.5, pp.933-942, 2010.

. Uhart, Loss Of Opportunity Linked With The Suboptimal Coverage Rate Of Hpv Vaccination In France, Value Health, vol.18, issue.7, p.462, 2015.

B. Dervaux, X. Lenne, D. Lévy-bruhl, and Y. Kudjawu, Modélisation médico-économique de l'impact de l'organisation du dépistage du cancer du col utérin et de l'introduction de la vaccination contre les HPV dans le calendrier vaccinal, Cresge et InVS, 2007.

M. T. Hall, K. T. Simms, J. Lew, M. A. Smith, J. M. Brotherton et al., The projected timeframe until cervical cancer elimination in Australia: a modelling study, The Lancet Public Health. 1 janv, vol.4, issue.1, pp.19-27, 2019.

W. T. Lim, K. Sears, L. M. Smith, G. Liu, and L. E. Lévesque, Evidence of effective delivery of the human papillomavirus (HPV) vaccine through a publicly funded, school-based program: the Ontario Grade 8 HPV Vaccine Cohort Study. BMC Public Health, 2014.

, Human papillomavirus vaccine coverage among female Australian adolescents: Success of the school-based approach

. Researchgate,

D. Sur,

, Achieving high and equitable coverage of adolescent HPV vaccine in Scotland

. Researchgate,

D. Sur,

, Literature review of HPV vaccine delivery strategies: Considerations for school-and non-school based immunization program -ScienceDirect

D. Sur,

, Factors associated with HPV vaccine uptake in teenage girls: A systematic review | Request PDF

. Researchgate,

E. B. Walling, N. Benzoni, J. Dornfeld, R. Bhandari, B. A. Sisk et al., Interventions to Improve HPV Vaccine Uptake: A Systematic Review, Pediatrics. 1 juill, vol.138, issue.1, p.20153863, 2016.

, Déterminants socio-économiques de vaccination et de dépistage du cancer du col par frottis cervico-utérin (FCU)Analyse de l'Enquête santé et protection sociale (ESPS), 2012.

H. Zou, A. E. Grulich, A. M. Cornall, S. N. Tabrizi, S. M. Garland et al., How very young men who have sex with men view vaccination against human papillomavirus, Vaccine, vol.32, issue.31, pp.3936-3977, 2014.

, PDF) Strategies intended to address vaccine hesitancy: Review of published reviews

. Researchgate,

D. Sur,

M. Drolet, É. Bénard, M. Boily, H. Ali, L. Baandrup et al., Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis, Lancet Infect Dis. mai, vol.15, issue.5, pp.565-80, 2015.

D. G. Regan, D. J. Philp, J. S. Hocking, and M. G. Law, Modelling the population-level impact of vaccination on the transmission of human papillomavirus type 16 in Australia, Sex Health. sept, vol.4, issue.3, pp.147-63, 2007.

R. F. Rubin, H. M. Kuttab, R. S. Rihani, and T. J. Reutzel, Patient adherence to three dose completion of the quadrivalent human papillomavirus (HPV) vaccine in a private practice, J Comm Health, vol.37, pp.1145-1150, 2012.

Y. Jiang, A. Gauthier, M. J. Postma, L. Ribassin-majed, N. Largeron et al., A critical review of cost-effectiveness analyses of vaccinating males against human papillomavirus, Hum Vaccin Immunother, vol.9, issue.11, pp.2285-95, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00862596

J. Olsen and T. R. Jørgensen, Revisiting the cost-effectiveness of universal HPV-vaccination in Denmark accounting for all potentially vaccine preventable HPV-related diseases in males and females, Cost Eff Resour Alloc. 11 févr, vol.13, issue.1, p.4, 2015.

, Human papillomavirus vaccines: WHO position paper, -Recommendations, vol.33, pp.4383-4384, 2014.

J. L. St-sauver, L. J. Finney-rutten, J. O. Ebbert, D. J. Jacobson, M. E. Mcgree et al., Younger age at initiation of the Human Papillomavirus (HPV) vaccination series is associated with higher rates of on-time completion, Prev Med. août, vol.89, pp.327-360, 2016.

S. L. Block, T. Nolan, C. Sattler, E. Barr, K. E. Giacoletti et al., Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women, Pediatrics, vol.118, pp.2135-2145, 2006.

C. Remschmidt, M. Fesenfeld, A. M. Kaufmann, and Y. Deleré, Sexual behavior and factors associated with young age at first intercourse and HPV vaccine uptake among young women in Germany: implications for HPV vaccination policies, vol.14

E. Godeau, C. Vignes, M. Duclos, F. Navarro, C. F. Grandjean et al., Factors associated with early sexual initiation in girls: French data from the international survey Health Behaviour in School

, Gynecol Obstet Fertil. févr, vol.36, issue.2, pp.176-82, 2008.

J. M. Hirth, A. Tan, G. S. Wilkinson, and A. B. Berenson, Completion of the Human Papillomavirus (HPV) Vaccine Series among Males with Private Insurance between, Vaccine. 6 févr, vol.31, issue.8, pp.1138-1178, 2006.

R. F. Rubin, H. M. Kuttab, R. S. Rihani, and T. J. Reutzel, Patient adherence to three dose completion of the quadrivalent human papillomavirus (HPV) vaccine in a private practice, J Comm Health, vol.37, pp.1145-1150, 2012.

C. Siegrist, E. M. Lewis, J. Eskola, S. Evans, and S. B. Black, Human papilloma virus immunization in adolescent and young adults: a cohort study to illustrate what events might be mistaken for adverse reactions, Pediatr Infect Dis J, vol.26, issue.11, pp.979-84, 2007.

, A randomized intervention of reminder letter for human papillomavirus vaccine series completion, J Adolesc Health, vol.56, issue.1, p.25438965, 2015.

, Effectiveness and net cost of reminder/recall for adolescent immunizations, Pediatrics, vol.129, issue.6, p.22566415, 2012.

E. B. Walling, N. Benzoni, J. Dornfeld, R. Bhandari, B. A. Sisk et al., Interventions to Improve HPV Vaccine Uptake: A Systematic Review, Pediatrics. 1 juill, vol.138, issue.1, p.20153863, 2016.

N. Williams, H. Woodward, A. Majeed, and S. Saxena, Primary care strategies to improve childhood immunisation uptake in developed countries: systematic review, Disponible sur, vol.2, 2011.

L. Y. Fu, L. Bonhomme, S. C. Cooper, J. G. Joseph, and G. D. Zimet, Educational interventions to increase HPV vaccination acceptance: A systematic review, Vaccine. 7 avr, vol.32, issue.17, 2014.

K. Ward, M. Chow, C. King, and J. Leask, Strategies to improve vaccination uptake in Australia, a systematic review of types and effectiveness, Australian and New Zealand Journal of Public Health, vol.36, issue.4, p.77, 2012.

. Gd, Parents with doubts about vaccines: which vaccines and reasons why

D. Sur,

, Vaccins anti-HPV : la couverture française et internationale [Internet]. REVUE GENESIS

, The Vaccine Confidence Project

, PDF) Decline in HPV-vaccination uptake in Denmark -The association between HPVrelated media coverage and HPV-vaccination

. Researchgate,

D. Sur,

H. O. Witteman and Z. Bj, The defining characteristics of Web 2.0 and their potential influence in the online vaccination debate, Vaccine. 28 mai, vol.30, issue.25, p.40, 2012.

, The Impact of Social Networks on Parents' Vaccination Decisions

. Researchgate,

D. Sur,

B. Corcoran, A. Clarke, and T. Barrett, Rapid response to HPV vaccination crisis in Ireland. The Lancet, vol.26, p.2103, 2018.

J. Heidi and . Larson, Measuring vaccine confidence: analysis of data obtained by a media surveillance system used to analyse public concerns about vaccines, Lancet Infect Dis, vol.13, pp.606-619, 2013.

, Disponible sur, 2014.

, Comité d'Orientation de la Concertation Citoyenne sur la Vaccination. Rapport sur la vaccination, Ministère des Affaires Sociales, de la Santé et des Droits des Femmes, 2016.

V. Scheduler and |. Ecdc,

, Glossaire AMM : Autorisation de mise sur le marché ANSM : Agence Nationale de Sécurité du Médicament CMU-c : Couverture Maladie Complémentaire universelle CV : Couverture Vaccinale FCU : Frottis cervico-utérin HAS : Haute autorité de santé HCSP : Haut conseil de la santé publique HPV : papillomavirus humain InVS : Institut de veille sanitaire IST : Infections sexuellement transmissibles OMS : Organisation mondiale de la santé RU : Royaume-Uni